Endocrinology, Diabetes & Metabolism Doctors in Santa Barbara, CA Accepting Medicare

8 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 8

Ashley Thorsell, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-7820    Fax: 805-681-7869

Dr. Jennifer Hone, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 345 Camino Del Remedio, Santa Barbara, CA 93110 Phone: 303-921-6740    Fax: 805-845-6002

Charles Christopher Donner, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-1761    Fax: 805-681-1768

Kateryna Markova, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-7820

Daniel Nathan Berger, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-1761    Fax: 805-681-1768

Muhammad Salman Ul Haq, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-1761    Fax: 805-681-1768

Dr. Karen Hougo, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 509 Lado Dr, Santa Barbara, CA 93111 Phone: 805-964-5552

Mark D Wilson, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-1761    Fax: 805-681-1768

News Archive

Medgenics signs $7 million agreement to develop the Biopump technology for Factor VIII

Medgenics is pleased to announce that it has signed a preclinical development and option agreement with a major international biopharmaceutical company that is a market leader in the field of hemophilia.

DSM licenses c-LEcta's alcohol dehydrogenases for enzyme screening programs

DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology.

Reusing masks may increase your risk of coronavirus infection, expert says

Panic buying and the hoarding of face masks to protect from the coronavirus disease (COVID-19) may not be a good idea, says a health expert. It puts you at an increased risk of contracting the virus.

Roche announces results of phase III taspoglutide study in diabetes patients

Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's research and developed by Roche.

Read more Medical News

› Verified 1 days ago